CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA

被引：2
|
作者：
TAKASHIMA, Y [1 ]
机构：
[1] MEIJO HOSP,PEDIAT CLIN,FEDERAT NATL PUBL SERV PERSONNEL MUTUAL AID ASSOC,NAKA KU,NAGOYA 460,JAPAN
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 04期
关键词：
D O I：
10.1002/j.1552-4604.1988.tb03158.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：356 / 362
页数：7
相关论文
共 50 条
  • [31] EXPERIENCE WITH INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    WILLEMZE, R
    FIBBE, WE
    ZWAAN, FE
    NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (08): : 215 - 219
  • [32] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE - REPLY
    DAMON, LE
    PLUNKETT, W
    LINKER, CA
    CANCER RESEARCH, 1992, 52 (13) : 3819 - 3820
  • [33] INVIVO DISTRIBUTION OF C-14-LABELED N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN MICE
    TOYOSHIMA, S
    FUKUMA, M
    SETO, Y
    FUJITA, H
    FUKUSHIMA, K
    TOMIOKA, H
    SAKURAI, T
    SUGIMOTO, Y
    YAGI, T
    HOSHINO, T
    SOWA, T
    GANN, 1981, 72 (01): : 19 - 29
  • [34] CLINICAL MEMORANDA - VASCULITIS AS A COMPLICATION OF HIGH-DOSE METHOTREXATE IN TREATMENT OF ACUTE-LEUKEMIA
    LANZKOWSKY, P
    JAYABOSE, S
    SHENDE, A
    LEVY, R
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1976, 130 (06): : 675 - 675
  • [35] HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN ADVANCED BREAST-CANCER
    FELDMAN, LD
    BUZDAR, AU
    BLUMENSCHEIN, GR
    ONCOLOGY, 1985, 42 (05) : 273 - 274
  • [36] Close correlation of 1-β-D-arabinofuranosylcytosine 5′-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N4-behenoyl-1-β-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia
    Yamauchi, T
    Kawai, Y
    Goto, N
    Kishi, S
    Imamura, S
    Yoshida, A
    Urasaki, Y
    Fukushima, T
    Iwasaki, H
    Tsutani, H
    Masada, M
    Ueda, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (09): : 975 - 982
  • [37] BUSULFAN PHARMACOKINETICS USING A SINGLE DAILY HIGH-DOSE REGIMEN IN CHILDREN WITH ACUTE-LEUKEMIA
    SHAW, PJ
    SCHARPING, CE
    BRIAN, RJ
    EARL, JW
    BLOOD, 1994, 84 (07) : 2357 - 2362
  • [38] RELATIONSHIP OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PLASMA TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE LEVELS IN LEUKEMIC-CELLS DURING TREATMENT WITH HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
    LILIEMARK, JO
    PLUNKETT, W
    DIXON, DO
    CANCER RESEARCH, 1985, 45 (11) : 5952 - 5957
  • [39] HIGH-DOSE CYTOSINE-ARABINOSIDE - CLINICAL-RESPONSE TO THERAPY IN ACUTE-LEUKEMIA
    EARLY, AP
    PREISLER, HD
    HIGBY, DJ
    BRECHER, M
    BROWMAN, G
    MCBRIDE, JA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 239 - 250
  • [40] CELLULAR PHARMACOLOGY AND OPTIMAL THERAPEUTIC CONCENTRATIONS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE IN LEUKEMIC BLASTS DURING TREATMENT OF REFRACTORY LEUKEMIA WITH HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
    PLUNKETT, W
    IACOBONI, S
    KEATING, MJ
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 36 : 51 - 59
12345